NasdaqCM - Delayed Quote • USD
Corcept Therapeutics Incorporated (CORT)
At close: April 24 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
127,039.00
127,039.00
120,323.00
167,892.00
151,970.00
Investing Cash Flow
90,906.00
90,906.00
-114,327.00
136,126.00
-119,263.00
Financing Cash Flow
-148,723.00
-148,723.00
-17,284.00
-302,591.00
12,214.00
End Cash Position
135,551.00
135,551.00
66,329.00
77,617.00
76,190.00
Income Tax Paid Supplemental Data
47,602.00
47,602.00
39,747.00
9,104.00
10,856.00
Capital Expenditure
-139.00
-139.00
-413.00
-469.00
-1,238.00
Repurchase of Capital Stock
-145,428.00
-145,428.00
--
-295,985.00
-9,945.00
Free Cash Flow
126,900.00
126,900.00
119,910.00
167,423.00
150,732.00
12/31/2020 - 4/14/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DAWN Day One Biopharmaceuticals, Inc.
15.19
-8.71%
JANX Janux Therapeutics, Inc.
48.21
-3.15%
CYTK Cytokinetics, Incorporated
66.82
+1.91%
IMVT Immunovant, Inc.
28.80
+0.66%
BHVN Biohaven Ltd.
38.72
-2.25%
APGE Apogee Therapeutics, Inc.
46.54
-6.49%
MLTX MoonLake Immunotherapeutics
42.43
-1.90%
ANRO Alto Neuroscience, Inc.
14.20
+2.31%
APLS Apellis Pharmaceuticals, Inc.
49.93
+2.48%
INCY Incyte Corporation
51.74
+0.17%